EMvision Common Stock vs Net Receivables Analysis

EMV Stock

1.80 0.05 2.70%

EMvision Medical financial indicator trend analysis is much more than just examining EMvision Medical Devices latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether EMvision Medical Devices is a good investment. Please check the relationship between EMvision Medical Common Stock and its Net Receivables accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Common Stock vs Net Receivables

Common Stock vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of EMvision Medical Devices Common Stock account and Net Receivables. At this time, the significance of the direction appears to have almost identical trend.

The correlation between EMvision Medical's Common Stock and Net Receivables is 0.9. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Net Receivables in the same time period over historical financial statements of EMvision Medical Devices, assuming nothing else is changed. The correlation between historical values of EMvision Medical's Common Stock and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of EMvision Medical Devices are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Common Stock i.e., EMvision Medical's Common Stock and Net Receivables go up and down completely randomly.

Correlation Coefficient

0.9

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Common Stock

Net Receivables

Most indicators from EMvision Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into EMvision Medical Devices current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in EMvision Medical Devices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

At this time, EMvision Medical's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 18.4 M in 2025, whereas Selling General Administrative is likely to drop slightly above 1.5 M in 2025.

	2022	2023	2024	2025 (projected)
Depreciation And Amortization	342.0K	410.6K	369.5K	351.0K
Interest Income	35.3K	341.2K	392.4K	412.0K

Depreciation And Amortization Interest Income

EMvision Medical fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Intangible Assets	Common Stock	Common Stock Total Equity	Non Current Liabilities Total	Net Invested Capital	Capital Stock	Net Working Capital	Short Long Term Debt Total
Total Assets		0.98	0.78	0.99	0.63	-0.96	-0.86	-0.23	1.0	0.97	0.69	1.0	0.91	0.84	0.98	0.75	0.9	1.0	0.82	0.99	0.77	0.92	0.98	0.89	0.96	0.91
Other Current Liab	0.98		0.77	0.97	0.48	-0.92	-0.81	-0.2	0.97	0.98	0.77	0.97	0.92	0.81	0.95	0.67	0.9	0.98	0.85	0.96	0.68	0.97	0.99	0.87	0.97	0.92
Total Current Liabilities	0.78	0.77		0.68	0.43	-0.73	-0.84	0.1	0.79	0.79	0.34	0.79	0.94	0.78	0.78	0.69	0.97	0.78	0.57	0.81	0.67	0.66	0.71	0.77	0.63	0.95
Total Stockholder Equity	0.99	0.97	0.68		0.65	-0.97	-0.82	-0.29	0.99	0.95	0.72	0.99	0.84	0.8	0.97	0.73	0.83	0.99	0.82	0.97	0.76	0.91	0.98	0.87	0.98	0.84
Net Tangible Assets	0.63	0.48	0.43	0.65		-0.75	-0.77	-0.42	0.67	0.55	0.03	0.67	0.39	0.61	0.71	0.83	0.46	0.63	0.3	0.7	0.84	0.3	0.52	0.63	0.51	0.43
Net Debt	-0.96	-0.92	-0.73	-0.97	-0.75		0.9	0.22	-0.97	-0.91	-0.6	-0.97	-0.83	-0.84	-0.96	-0.82	-0.83	-0.97	-0.78	-0.97	-0.84	-0.81	-0.92	-0.92	-0.91	-0.84
Retained Earnings	-0.86	-0.81	-0.84	-0.82	-0.77	0.9		0.27	-0.88	-0.88	-0.26	-0.88	-0.82	-0.91	-0.91	-0.95	-0.87	-0.86	-0.61	-0.93	-0.9	-0.66	-0.77	-0.91	-0.73	-0.86
Accounts Payable	-0.23	-0.2	0.1	-0.29	-0.42	0.22	0.27		-0.22	-0.31	0.04	-0.22	0.02	-0.34	-0.32	-0.41	-0.01	-0.22	-0.05	-0.28	-0.26	-0.19	-0.27	-0.2	-0.3	-0.02
Cash	1.0	0.97	0.79	0.99	0.67	-0.97	-0.88	-0.22		0.96	0.66	1.0	0.9	0.85	0.98	0.78	0.9	1.0	0.8	0.99	0.8	0.89	0.97	0.9	0.95	0.91
Non Current Assets Total	0.97	0.98	0.79	0.95	0.55	-0.91	-0.88	-0.31	0.96		0.62	0.96	0.91	0.87	0.97	0.78	0.91	0.97	0.8	0.98	0.74	0.93	0.95	0.89	0.93	0.93
Non Currrent Assets Other	0.69	0.77	0.34	0.72	0.03	-0.6	-0.26	0.04	0.66	0.62		0.66	0.62	0.36	0.57	0.1	0.52	0.7	0.78	0.58	0.2	0.84	0.79	0.49	0.82	0.57
Cash And Short Term Investments	1.0	0.97	0.79	0.99	0.67	-0.97	-0.88	-0.22	1.0	0.96	0.66		0.9	0.84	0.98	0.77	0.9	1.0	0.8	0.99	0.79	0.89	0.97	0.9	0.95	0.91
Net Receivables	0.91	0.92	0.94	0.84	0.39	-0.83	-0.82	0.02	0.9	0.91	0.62	0.9		0.81	0.87	0.65	0.99	0.91	0.75	0.9	0.65	0.86	0.88	0.83	0.83	0.99
Common Stock Shares Outstanding	0.84	0.81	0.78	0.8	0.61	-0.84	-0.91	-0.34	0.85	0.87	0.36	0.84	0.81		0.85	0.89	0.84	0.84	0.77	0.88	0.89	0.71	0.8	0.95	0.76	0.84
Other Current Assets	0.98	0.95	0.78	0.97	0.71	-0.96	-0.91	-0.32	0.98	0.97	0.57	0.98	0.87	0.85		0.84	0.88	0.98	0.76	0.99	0.78	0.86	0.94	0.9	0.92	0.89
Other Stockholder Equity	0.75	0.67	0.69	0.73	0.83	-0.82	-0.95	-0.41	0.78	0.78	0.1	0.77	0.65	0.89	0.84		0.72	0.75	0.56	0.84	0.91	0.53	0.65	0.88	0.62	0.7
Total Liab	0.9	0.9	0.97	0.83	0.46	-0.83	-0.87	-0.01	0.9	0.91	0.52	0.9	0.99	0.84	0.88	0.72		0.9	0.71	0.91	0.7	0.82	0.85	0.85	0.8	1.0
Total Current Assets	1.0	0.98	0.78	0.99	0.63	-0.97	-0.86	-0.22	1.0	0.97	0.7	1.0	0.91	0.84	0.98	0.75	0.9		0.82	0.99	0.77	0.91	0.98	0.89	0.97	0.91
Intangible Assets	0.82	0.85	0.57	0.82	0.3	-0.78	-0.61	-0.05	0.8	0.8	0.78	0.8	0.75	0.77	0.76	0.56	0.71	0.82		0.77	0.6	0.86	0.85	0.87	0.85	0.74
Common Stock	0.99	0.96	0.81	0.97	0.7	-0.97	-0.93	-0.28	0.99	0.98	0.58	0.99	0.9	0.88	0.99	0.84	0.91	0.99	0.77		0.83	0.87	0.95	0.91	0.92	0.92
Common Stock Total Equity	0.77	0.68	0.67	0.76	0.84	-0.84	-0.9	-0.26	0.8	0.74	0.2	0.79	0.65	0.89	0.78	0.91	0.7	0.77	0.6	0.83		0.51	0.67	0.87	0.64	0.68
Non Current Liabilities Total	0.92	0.97	0.66	0.91	0.3	-0.81	-0.66	-0.19	0.89	0.93	0.84	0.89	0.86	0.71	0.86	0.53	0.82	0.91	0.86	0.87	0.51		0.96	0.78	0.95	0.86
Net Invested Capital	0.98	0.99	0.71	0.98	0.52	-0.92	-0.77	-0.27	0.97	0.95	0.79	0.97	0.88	0.8	0.94	0.65	0.85	0.98	0.85	0.95	0.67	0.96		0.85	1.0	0.88
Capital Stock	0.89	0.87	0.77	0.87	0.63	-0.92	-0.91	-0.2	0.9	0.89	0.49	0.9	0.83	0.95	0.9	0.88	0.85	0.89	0.87	0.91	0.87	0.78	0.85		0.83	0.85
Net Working Capital	0.96	0.97	0.63	0.98	0.51	-0.91	-0.73	-0.3	0.95	0.93	0.82	0.95	0.83	0.76	0.92	0.62	0.8	0.97	0.85	0.92	0.64	0.95	1.0	0.83		0.82
Short Long Term Debt Total	0.91	0.92	0.95	0.84	0.43	-0.84	-0.86	-0.02	0.91	0.93	0.57	0.91	0.99	0.84	0.89	0.7	1.0	0.91	0.74	0.92	0.68	0.86	0.88	0.85	0.82

Click cells to compare fundamentals

EMvision Medical Account Relationship Matchups

EMvision Medical fundamental ratios Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	10.8M	8.5M	11.5M	24.0M	27.6M	28.9M
Other Current Liab	313.1K	478.9K	682.7K	2.1M	2.4M	2.5M
Total Current Liabilities	676.2K	854.0K	6.0M	3.4M	3.9M	4.1M
Total Stockholder Equity	10.1M	7.1M	5.1M	18.5M	21.3M	22.4M
Net Tangible Assets	5.0M	9.6M	6.6M	4.6M	5.3M	5.6M
Net Debt	(9.5M)	(6.1M)	(6.9M)	(15.7M)	(14.1M)	(13.4M)
Retained Earnings	(15.7M)	(21.8M)	(25.7M)	(26.5M)	(23.9M)	(22.7M)
Accounts Payable	193.7K	178.2K	330.7K	293.5K	264.1K	221.1K
Cash	9.7M	6.8M	10.0M	18.6M	21.4M	22.5M
Non Current Assets Total	798.7K	1.4M	1.3M	2.1M	2.4M	2.5M
Non Currrent Assets Other	(798.7K)	(1.4M)	(1.3M)	652.1K	749.9K	787.4K
Cash And Short Term Investments	9.7M	6.8M	10.0M	18.7M	21.5M	22.5M
Net Receivables	81.3K	117.4K	69.9K	2.8M	3.2M	3.4M
Common Stock Shares Outstanding	70.1M	75.2M	77.7M	80.4M	92.5M	73.8M
Liabilities And Stockholders Equity	10.8M	8.5M	11.5M	24.0M	27.6M	28.9M
Inventory	(38.0K)	51.1K	130.1K	(65.0K)	(74.8K)	(71.0K)
Other Current Assets	285.8K	269.8K	265.2K	463.5K	533.0K	559.6K
Other Stockholder Equity	840.6K	4.3M	5.7M	4.5M	5.2M	2.9M
Total Liab	720.0K	1.4M	6.4M	5.5M	6.3M	6.6M
Total Current Assets	10.0M	7.1M	10.2M	21.9M	25.1M	26.4M
Common Stock	21.4M	23.2M	26.2M	41.6M	47.8M	50.2M
Non Current Liabilities Total	43.8K	571.6K	365.9K	2.0M	2.3M	2.5M
Net Invested Capital	10.1M	7.1M	7.6M	21.1M	24.3M	25.5M
Accumulated Other Comprehensive Income	4.3M	5.7M	4.5M	3.5M	4.0M	3.6M
Capital Stock	21.4M	23.2M	26.2M	41.6M	47.8M	24.2M
Net Working Capital	9.3M	6.2M	4.2M	18.5M	21.2M	22.3M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for EMvision Stock Analysis

When running EMvision Medical's price analysis, check to measure EMvision Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EMvision Medical is operating at the current time. Most of EMvision Medical's value examination focuses on studying past and present price action to predict the probability of EMvision Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EMvision Medical's price. Additionally, you may evaluate how the addition of EMvision Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC